November 27, 2020

The Niche

Knoepfler lab stem cell blog

Multiple Sclerosis covid-19

3 min read

I’m continuing my stem cell patient Q&A series and today’s Q&A#2 post is focused on whether autoimmune patients generally or specifically those who have received chemo and hematopoietic stem cell transplants (HSCT) are at higher risk from COVID-19? Multiple patients have asked me this. It’s a great question and obviously urgent right now during the outbreak. BTW, You can read patient Q&A#1 from this Q&A series on the potential for stem cell clinics to put patients at risk of graft-vs-host disease via stem cell …Read More